Gene · 5734
Papers4,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Digital Biomarkers for Precision Early Detection of Lung Cancer: Integrating AI-Driven Multi-Omics Into Clinical Pathways. | Cancer Med | 2026 | 41645653 | PubTator, text mining | PubMed |
| Psychometric validation of the Existence, Relatedness, and Growth (ERG) scale for Indonesian generation Z employees. | BMC Psychol | 2026 | 41634878 | PubTator, text mining | PubMed |
| Signaling pathways and molecular mechanisms of lupeol in colorectal cancer: A comprehensive review. | J Ayurveda Integr Med | 2026 | 41616596 | PubTator, text mining | PubMed |
| Platelets in the tumor microenvironment: potential mediators of immune exclusion and resistance to immune checkpoint inhibitor therapy. | Cell Oncol (Dordr) | 2026 | 41609891 | PubTator, text mining | PubMed |
| Genetic risk factors for pneumonia differ by patient subgroup. | EBioMedicine | 2026 | 41579494 | PubTator, text mining | PubMed |
| Evaluating the Process of Patient Engagement: Insights from a Mixed-Methods Evaluation of a Cancer Center Patient Advisory Group. | Health Expect | 2026 | 41578896 | PubTator, text mining | PubMed |
| Lack of Association Between PTGER4 Polymorphisms and Acute Anterior Uveitis in Chinese Population. | Ocul Immunol Inflamm | 2026 | 41575487 | PubTator, text mining | PubMed |
| EP4 stimulation promotes cell adhesion and migration via IL-6 signaling in oral squamous cell carcinoma. | J Physiol Sci | 2026 | 41570590 | PubTator, text mining | PubMed |
| ACSL5 Mediates Adaptation to the Palmitic Acid-Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis. | Cancer Res | 2026 | 41570334 | PubTator, text mining | PubMed |
| Single-cell transcriptomics uncovers malignant potential of gallbladder adenomyomatosis and identifies PRDX1+ immunosuppressive macrophages in gallbladder carcinoma. | Int J Surg | 2026 | 41570280 | PubTator, text mining | PubMed |
| Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m6A-Dependent hnRNPA2B1/COX-2 Axis. | Adv Sci (Weinh) | 2026 | 41566573 | PubTator, text mining | PubMed |
| Recent progress in immunomodulation-based strategies for bone repair. | Regen Ther | 2026 | 41537150 | PubTator, text mining | PubMed |
| LL-37 and citrullinated-LL-37 enhances oxylipins: citrullination attenuates LL-37-mediated COX-2-dependent chemokine response in human bronchial epithelial cells. | Respir Res | 2026 | 41535907 | PubTator, text mining | PubMed |
| Abstracts from the 6th Annual Conference of Emirates Society of Internal Medicine (ESIM) 2025. | BMC Proc | 2026 | 41501744 | PubTator, text mining | PubMed |
| Gallic acid-conjugated 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone induces apoptosis and downregulates PI3K/Akt signaling through VEGFR-2 targeting in non-small cell lung cancer (NSCLC). | Biomed Pharmacother | 2026 | 41496366 | PubTator, text mining | PubMed |
| Azoheteroarene-Modified Grapiprants Serving as Photoswitchable EP4 Antagonists. | Chemistry | 2026 | 41467639 | PubTator, text mining | PubMed |
| Anti-inflammatory perylenequinones from the endolichenic fungus Phialocephala fortinii triggered by a histone deacetylase inhibitor. | Fitoterapia | 2026 | 41443515 | PubTator, text mining | PubMed |
| Computational evaluation of indole alkaloids as inhibitors of 3-hydroxykynurenine transaminase in malaria vector control. | Comput Biol Chem | 2026 | 41391264 | PubTator, text mining | PubMed |
| The dual role of the COX-2/PGE2 Axis in multiple sclerosis: From pathogenesis to pharmacological inhibition. | Clin Immunol | 2026 | 41285355 | PubTator, text mining | PubMed |
| Revisiting prostaglandin biology in pulmonary arterial hypertension: targeting the EP4/ANXA2 axis. | Eur Heart J | 2026 | 41259070 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5734/papers?page=4